C-X-C motif chemokine ligand 13 suppresses osteoclast differentiation via interference with RANKL–RANK interaction
These findings identify CXCL13 as a novel suppressor of osteoclastogenesis by interfering with RANKL-RANK signaling, unveiling an unrecognized regulatory role in osteoclast biology and suggesting potential therapeutic relevance for bone loss disorders.
Authors
- David Achudhan (ORCID: https://orcid.org/0000-0002-2917-0578)
- Chun-Lin Liu
- Jeng-Hung Guo
- Chih-Hsin Tang
- Le Huynh Hoai Thuong
- Chien-Tai Ren
- Kun-Tsan Lee
- Chih-Yuan Ko
- Yu-Hao He
- Trung-Loc Ho
Institutions
- Mayo Clinic (US)
- Asia University (TW)
- National Chung Hsing University (TW)
- China Medical University (TW)
- Taichung Veterans General Hospital (TW)
- Mayo Clinic in Arizona (US)
- China Medical University Hospital (TW)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.3389/fimmu.2025.1729222
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00